Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-Mediated Rejection”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Not applicableNot Yet RecruitingNCT06774365
What this trial is testing

CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation

Who this might be right for
Heart TransplantationRejection Heart TransplantHLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna 683
Not applicableNot Yet RecruitingNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Early research (Phase 1)Looking for participantsNCT06990711
What this trial is testing

Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Who this might be right for
Antibody Mediated Rejection of Lung Transplant
Washington University School of Medicine 30
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT06291103
What this trial is testing

Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

Who this might be right for
Kidney Transplant Rejection
University Hospital, Rouen 290
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT03897205
What this trial is testing

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 30
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02474927
What this trial is testing

Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation

Who this might be right for
Lung Transplant Rejection
John F. McDyer, MD 22
Not applicableStudy completedNCT02294032
What this trial is testing

The Role of B Cells in Kidney Allograft Dysfunction

Who this might be right for
Kidney; Complications, AllograftTransplantation Infection
Loma Linda University 180
Not applicableLooking for participantsNCT07134491
What this trial is testing

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Who this might be right for
Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris 45
Not applicableUnknownNCT03430414
What this trial is testing

Analysis of Biopsies With Antibody Mediated Rejection According to the Therapy Response

Who this might be right for
Antibody-mediated Rejection
Thomas Mueller 50
Testing effectiveness (Phase 2)Study completedNCT05021484
What this trial is testing

Felzartamab in Late Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated Rejection
Farsad Eskandary 22
Not applicableUnknownNCT05140018
What this trial is testing

Incidence, Course and Outcome of ABMR in Kidney Transplantation

Who this might be right for
Antibody-mediated RejectionKidney TransplantationImmunosuppression
University Medical Center Groningen 225
Early research (Phase 1)Not Yet RecruitingNCT06948097
What this trial is testing

Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies

Who this might be right for
Lung Transplantation
National Heart, Lung, and Blood Institute (NHLBI) 30
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Testing effectiveness (Phase 2)Study completedNCT01873157
What this trial is testing

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Who this might be right for
Late Rejection of Renal TransplantAntibody-mediated Rejection
Medical University of Vienna 44
Load More Results